Abstract
Fibrocytes were initially described in 1999 and since that time there has been a growing body of literature to suggest their importance in a number of chronic lung diseases. It is now well established that fibrocytes derive from the bone marrow and circulate within the peripheral blood. However, when injury occurs, fibrocytes can travel to the site of damage via chemokine-mediated recruitment. Recent studies suggest that fibrocyte numbers increase within the lung or circulation during numerous disease processes. Although fibrocytes readily differentiate into fibroblasts in vitro, whether they do so readily in vivo is still unclear. Additionally, while human studies often show evidence of α-smooth muscle actin (SMA) expression in fibrocytes, this is less common in murine studies. A variety of pro-fibrotic mediators that are secreted by fibrocytes make it likely that they can act via paracrine functions to influence the behavior of resident lung cells. This review summarizes recent insights regarding fibrocytes in asthma, scleroderma and IPF.
Keywords: Bone marrow, chemokines, fibroblasts, fibrocytes, fibrosis, lung.
Current Respiratory Medicine Reviews
Title:Fibrocytes in the Pathogenesis of Chronic Fibrotic Lung Disease
Volume: 9 Issue: 1
Author(s): Hillary Loomis-King and Bethany B. Moore
Affiliation:
Keywords: Bone marrow, chemokines, fibroblasts, fibrocytes, fibrosis, lung.
Abstract: Fibrocytes were initially described in 1999 and since that time there has been a growing body of literature to suggest their importance in a number of chronic lung diseases. It is now well established that fibrocytes derive from the bone marrow and circulate within the peripheral blood. However, when injury occurs, fibrocytes can travel to the site of damage via chemokine-mediated recruitment. Recent studies suggest that fibrocyte numbers increase within the lung or circulation during numerous disease processes. Although fibrocytes readily differentiate into fibroblasts in vitro, whether they do so readily in vivo is still unclear. Additionally, while human studies often show evidence of α-smooth muscle actin (SMA) expression in fibrocytes, this is less common in murine studies. A variety of pro-fibrotic mediators that are secreted by fibrocytes make it likely that they can act via paracrine functions to influence the behavior of resident lung cells. This review summarizes recent insights regarding fibrocytes in asthma, scleroderma and IPF.
Export Options
About this article
Cite this article as:
Loomis-King Hillary and Moore Bethany B., Fibrocytes in the Pathogenesis of Chronic Fibrotic Lung Disease, Current Respiratory Medicine Reviews 2013; 9 (1) . https://dx.doi.org/10.2174/1573398X11309010005
DOI https://dx.doi.org/10.2174/1573398X11309010005 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Review of Flavonoids from Cassia Species and their Biological Activity
Current Pharmaceutical Biotechnology The Dual Role of Microglia in Blood-Brain Barrier Dysfunction after Stroke
Current Neuropharmacology Aerosol Performance of Large Respirable Particles of Amikacin Sulfate Produced by Spray and Freeze Drying Techniques
Current Drug Delivery Genetic Dissection of Complex Traits In Silico: Approaches, Problems and Solutions
Current Bioinformatics Phosphodiesterase 5 Inhibitors - Drug Design and Differentiation Based on Selectivity, Pharmacokinetic and Efficacy Profiles
Current Pharmaceutical Design Should Serology be Abolished in Favor of PCR for the Diagnosis of Mycoplasma pneumoniae Infections?
Current Pediatric Reviews Diabetogenic Effects of Parthinium hysterophorous Induced Allergic Rhinitis
Inflammation & Allergy - Drug Targets (Discontinued) Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives
Current Pharmaceutical Design Regulatory T Cells in Central Nervous System: in Health and Disease
Central Nervous System Agents in Medicinal Chemistry Nummular Eczema: An Updated Review
Recent Patents on Inflammation & Allergy Drug Discovery Supercritical Fluid Chromatographic Method for Montelukast: Application in Content Uniformity and Degradation Study
Current Analytical Chemistry In-Silico Analysis and Molecular Docking Studies of Potential Phosphodiesterase 4 Inhibitors using Ventilago Isolates
Letters in Organic Chemistry Inflammasome Signaling in Pathogenesis of Lung Diseases
Current Pharmaceutical Design The Nitric Oxide View: Perspectives and Applications
Current Medicinal Chemistry Opioid and Cannabinoid System in Food Intake
Current Pharmaceutical Design New Treatments for COPD in the Elderly
Current Pharmaceutical Design Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors
Current Medicinal Chemistry Antiviral Activity and Molecular Targets of Plant Natural Products Against Avian Influenza Virus
Current Organic Chemistry Asthma and High Altitude: Is It Safe to Be and Work?
Current Respiratory Medicine Reviews The Role of Mast Cells in the Structural Alterations of the Airways as a Potential Mechanism in the Pathogenesis of Severe Asthma
Current Pharmaceutical Design